pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON
Disc Medicine
Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 308
- Drugs
- 443
- Patents
- 706
18-791
Phase 3 · small molecule · Brain injury in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass.
18-791 for Brain injury in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass. is a Phase 3 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Internal code 18-791
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Disc Medicine
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Brain injury in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass.
- Status
- active
- Trials
- 1